Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Run-Ling Wang

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
1-(4-Methoxy-phen-yl)imidazolidine-2,4-dioneSu-Xia Sun, Hao Zhang, Xian-Chao Cheng, et al.
Journal of Biomolecular Structure & Dynamics|December 18, 2019
Identification of the potential dual inhibitor of protein tyrosine phosphatase sigma and leukocyte common antigen-related phosphatase by virtual screen, molecular dynamic simulations and post-analysisLiang Zhou, Yang-Chun Ma, Xue Tang, et al.
Biochemical and Biophysical Research Communications|September 21, 2010
Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of influenza virusShu-Qing Wang, Xian-Chao Cheng, Wei-Li Dong, et al.
Plos One|November 3, 2012
Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptorsLi-Song Zhang, Shu-Qing Wang, Wei-Ren Xu, et al.
Acta Crystallographica. Section E, Structure Reports Online|July 15, 2011
Methyl 3,4-bis-(cyclo-propyl-meth-oxy)benzoateXian-Chao Cheng, Jing-Jing Hou, Cheng-Zhi Xie, et al.
Plos One|December 6, 2011
Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping methodXiao-Bo Li, Shu-Qing Wang, Wei-Ren Xu, et al.
Journal of Cellular Biochemistry|August 22, 2018
Exploring the effect of E76K mutation on SHP2 cause gain-of-function activity by a molecular dynamics studyWei-Ya Li, Hui-Yu Wei, Ying-Zhan Sun, et al.
Drug Design, Development and Therapy|May 1, 2013
Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformaticsLei Liu, Ying Ma, Run-Ling Wang, et al.
Journal of Biomolecular Structure & Dynamics|January 22, 2019
Exploring the cause of the inhibitor 4AX attaching to binding site disrupting protein tyrosine phosphatase 4A1 trimerization by molecular dynamic simulationLi Wei-Ya, Duan Yu-Qing, Ma Yang-Chun, et al.
Journal of Biomolecular Structure & Dynamics|November 11, 2017
Exploring the effect of D61G mutation on SHP2 cause gain of function activity by a molecular dynamics studyHong-Lian Li, Ying Ma, Chang-Jie Zheng, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
1-(4-Methoxy-phen-yl)imidazolidine-2,4-dioneSu-Xia Sun, Hao Zhang, Xian-Chao Cheng, et al.
Journal of Biomolecular Structure & Dynamics|December 18, 2019
Identification of the potential dual inhibitor of protein tyrosine phosphatase sigma and leukocyte common antigen-related phosphatase by virtual screen, molecular dynamic simulations and post-analysisLiang Zhou, Yang-Chun Ma, Xue Tang, et al.
Biochemical and Biophysical Research Communications|September 21, 2010
Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of influenza virusShu-Qing Wang, Xian-Chao Cheng, Wei-Li Dong, et al.
Plos One|November 3, 2012
Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptorsLi-Song Zhang, Shu-Qing Wang, Wei-Ren Xu, et al.
Acta Crystallographica. Section E, Structure Reports Online|July 15, 2011
Methyl 3,4-bis-(cyclo-propyl-meth-oxy)benzoateXian-Chao Cheng, Jing-Jing Hou, Cheng-Zhi Xie, et al.
Plos One|December 6, 2011
Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping methodXiao-Bo Li, Shu-Qing Wang, Wei-Ren Xu, et al.
Journal of Cellular Biochemistry|August 22, 2018
Exploring the effect of E76K mutation on SHP2 cause gain-of-function activity by a molecular dynamics studyWei-Ya Li, Hui-Yu Wei, Ying-Zhan Sun, et al.
Drug Design, Development and Therapy|May 1, 2013
Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformaticsLei Liu, Ying Ma, Run-Ling Wang, et al.
Journal of Biomolecular Structure & Dynamics|January 22, 2019
Exploring the cause of the inhibitor 4AX attaching to binding site disrupting protein tyrosine phosphatase 4A1 trimerization by molecular dynamic simulationLi Wei-Ya, Duan Yu-Qing, Ma Yang-Chun, et al.
Journal of Biomolecular Structure & Dynamics|November 11, 2017
Exploring the effect of D61G mutation on SHP2 cause gain of function activity by a molecular dynamics studyHong-Lian Li, Ying Ma, Chang-Jie Zheng, et al.
Pageof 6